Device type · LFH
U.V. Spectrometry, Tricyclic Antidepressant Drugs
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LFH
Clinical Toxicology
Device class
Class II
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- U.V. Spectrometry, Tricyclic Antidepressant Drugs
- Product code
- LFH
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3910
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for LFH
Latest FDA decisions
K231020 · Decided Nov 17, 2023 · 221 days after receipt
Device type: U.V. Spectrometry, Tricyclic Antidepressant Drugs (LFH) · Laboratory Medicine & Pathology
K213875 · Decided Dec 21, 2022 · 373 days after receipt
Device type: U.V. Spectrometry, Tricyclic Antidepressant Drugs (LFH) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Alere iScreen Dx Urine Drug Screen CardTerminated
Z-1542-2018 · Started Dec 15, 2017
Reason given: The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box.
Cause as FDA categorized it: Labeling Change Control
Z-3084-2017 · Started Jun 26, 2017
Reason given: The kit box label incorrectly identifies PCP (instead of TCA) as one of the 10 drug analytes included in the kit. The pouch label, product insert, and the device itself are labeled correctly.
Cause as FDA categorized it: Labeling Change Control
Z-0324-04 · Started Nov 17, 2003 · Posted by FDA Jan 10, 2004
Reason given: Drug product cross reacts with the Tricyclic Antidepressants (TCA) assay.
Cause as FDA categorized it: Other
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.